Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54207-6 Coagulation surface induced.factor substitution^immediately after addition of factor V depleted plasma Time PPP Pt Qn Coag   ACTIVE aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma   MIN DefinitionDescription     s APC-1 35 secoonds.           COAG   54207-6   Coag     Observation       0 aPTT imm FV DP PPP       N   Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Factor 5; FV; Hematology; Heme; imm FV DP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube 2.52 2.27               s       0
54208-4 Coagulation surface induced.factor substitution^immediately after addition of factor V depleted plasma+APC Time PPP Pt Qn Coag   ACTIVE aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma+APC   MIN DefinitionDescription     s APC-2 78 seconds.           COAG   54208-4   Coag     Observation       0 aPTT imm FV DP+APC PPP       N   Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Factor 5; FV; Hematology; Heme; imm FV DP; imm FV DP+APC; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube 2.52 2.27               s       0
54209-2 Hemoglobin C-Harlem/Hemoglobin.total MFr Bld Pt Qn     ACTIVE Hemoglobin C - Harlem/Hemoglobin.total in Blood   MIN DefinitionDescription     %             HEM/BC   54209-2         Both       0 Hgb C-Harlem MFr Bld       N   Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hemoglobin C - Harlam; Hgb; Hgb C; Hgb C-Harlem; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.3 2.27               %       0
5421-3 CD106 ACnc WBC Pt Qn     DEPRECATED Deprecated CD106 cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5421-3                 0 Deprecated CD106 WBC-aCnc           Arbitrary concentration; CELL MARKERS; INCAM-110; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Vascular cell adhesion molecule-1; VCAM1; VCAM-1; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54210-0 Hepatitis B virus basal core promoter mutation Prid Ser Pt Nom Probe.amp.tar   ACTIVE Hepatitis B virus basal core promoter mutation [Identifier] in Serum by NAA with probe detection   MIN DefinitionDescription                   MICRO   54210-0   Probe.amp.tar     Both       0 HBV BCP Mut Ser NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HBV; HBV BCP; HBV BCP Mut; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; Mut; Mutations; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification 2.73 2.27                       0
54211-8 Cortisol^24H post dose dexamethasone SCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Moles/volume] in Serum or Plasma --24 hours post dose dexamethasone   MIN DefinitionDescription     nmol/L             CHAL   54211-8         Observation       0 Cortis 24h p DEX SerPl-sCnc       N   17-Hydroxycorticosterone; 24h p DEX; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               nmol/L       0
54212-6 Cortisol^3D post dose dexamethasone SCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Moles/volume] in Serum or Plasma --3 days post dose dexamethasone   MIN DefinitionDescription     nmol/L             CHAL   54212-6         Both       0 Cortis 3D p Dex SerPl-sCnc       N   17-Hydroxycorticosterone; 3D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               nmol/L       0
54213-4 Cortisol^4D post dose corticotropin SCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Moles/volume] in Serum or Plasma --4 days post dose corticotropin   MIN DefinitionDescription     nmol/L             CHAL   54213-4         Observation       0 Cortis 4D p Dex SerPl-sCnc       N   17-Hydroxycorticosterone; 4D p Dex; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortrosyn; F; hydrocortisone; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker 2.7 2.27               nmol/L       0
54214-2 Cortisol^5D post dose dexamethasone SCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Moles/volume] in Serum or Plasma --5 days post dose dexamethasone   MIN DefinitionDescription     nmol/L             CHAL   54214-2         Observation       0 Cortis 5D p Dex SerPl-sCnc       N   17-Hydroxycorticosterone; 5D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               nmol/L       0
54215-9 Cortisol^5H post dose corticotropin SCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Moles/volume] in Serum or Plasma --5 hours post dose corticotropin   MIN DefinitionDescription     nmol/L             CHAL   54215-9         Observation       0 Cortis 5h p Dex SerPl-sCnc       N   17-Hydroxycorticosterone; 5h p Dex; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortrosyn; F; hydrocortisone; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker 2.7 2.27               nmol/L       0
54216-7 Insulin-like growth factor binding protein 1^pre or post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma --pre or post XXX challenge   MIN DefinitionDescription     mg/L             CHAL   54216-7         Observation       0 IGF BP1 pre/p chal SerPl-mCnc       N   After; Before; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; i; IGF; IGF BP; IGF BP1; IGFBP; IGFBP1; IGFBP-1; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; pre/p chal; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.7 2.27               mg/L       0
54217-5 Public health notifiable condition Prid XXX Pt Nom     ACTIVE Public health notifiable condition   MIN DefinitionDescription                   CLIN   54217-5         Observation       0 PH notifiable condition       N   CLIN; Identity or presence; Misc; Miscellaneous; Nominal; Other; PH notifiable condition; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.56 2.27                     Changed answer list from "Normative" to "Preferred" to fit the current LOINC model. 0
54218-3 Cells.CD3+CD4+/Cells.CD3+CD8+ NRto Bld Pt Qn     ACTIVE CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood   MIN DefinitionDescription     ratio             CELLMARK   54218-3         Both       0 CD3+CD4+ Cells/CD3+CD8+ Cll Bld       N   Blood; CD3 Cells; CD3+CD4+ Cells; CD3+CD8+ Cells; CD3+CD8+ Cll; CD3-CD4+; CD4+ T cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Leu4; Leu-4; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T4; T-4; T4 helper/inducer cells; T8; T-8; T8 suppressor cells; Tsuppressor; W3/25; WB; Whole blood 2.79 2.27               %       0
54219-1 Coagulation thrombin induced.factor substitution^immediately after 1:4 addition of normal plasma Time PPP Pt Qn Coag   ACTIVE Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma   MIN DefinitionDescription     s this means that if a patient is on argatroban, lepirudin or a thrombin inhibitor, then a provider can order this test and it should help the provider with the care/treatment of the patient. Ref Range Comments: Therapeutic ranges are: Lepirudin: 90-160 s Argatroban: 60-100 s Bivalirudin: 60-90 s           COAG   54219-1   Coag     Observation       0 TT imm 1:4 NP PPP       N   Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; imm 1:4 NP; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; TCT; Throm; Thrombin clotting time; Thrombin time; Tilt tube; TT 2.73 2.27               s       0
5422-1 CD107a ACnc WBC Pt Qn     DEPRECATED Deprecated CD107a cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5422-1                 0 Deprecated CD107a WBC-aCnc           Arbitrary concentration; CELL MARKERS; LAMP-1; Leukocytes; Lysosome-associated membrane-protein 1; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54220-9 Immune response markers Imp XXX Pt Nar     ACTIVE Immune response markers [Interpretation] in Specimen Narrative   MIN DefinitionDescription                   CELLMARK   54220-9         Observation       0 Immune response markers Spec-Imp       N   CELL MARKERS; Imm; Impression; Impression/interpretation of study; Impressions; Imun; Imune; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified 2.69 2.27                       0
54221-7 Lymphoma markers Imp XXX Pt Nar     ACTIVE Lymphoma markers [Interpretation] in Specimen Narrative   MIN DefinitionDescription                   CELLMARK   54221-7         Observation       0 Lymphoma markers Spec-Imp       N   CELL MARKERS; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified 2.69 2.27                       0
54222-5 Lymphoma - acute screen markers Imp XXX Pt Nar     ACTIVE Lymphoma - acute screen markers [Interpretation] in Specimen Narrative   MIN DefinitionDescription                   CELLMARK   54222-5         Observation       0 Lymphoma - acute screen markers Spec-Imp       N   CELL MARKERS; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Scn; Scr; Scrn; Spec; To be specified in another part of the message; Unspecified 2.73 2.27                       0
54223-3 Lymphoma - CLL screen markers Imp XXX Pt Nar     ACTIVE Lymphoma - CLL screen markers [Interpretation] in Specimen Narrative   MIN DefinitionDescription                   CELLMARK   54223-3         Observation       0 Lymphoma - CLL screen markers Spec-Imp       N   CELL MARKERS; Chronic lymphocytic leukemia; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Scn; Scr; Scrn; Spec; To be specified in another part of the message; Unspecified 2.69 2.27                       0
54224-1 Lymphoma - T-cell markers Imp XXX Pt Nar     ACTIVE Lymphoma - T-cell markers [Interpretation] in Specimen Narrative   MIN DefinitionDescription                   CELLMARK   54224-1         Observation       0 Lymphoma - T-cell markers Spec-Imp       N   Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; T cell; T prime; To be specified in another part of the message; UCHL-1; Unspecified 2.69 2.27                       0
54225-8 Immune response panel - XXX Pt - Flow cytometry   ACTIVE Immune response panel - Specimen by Flow cytometry (FC)   MIN DefinitionDescription                   PANEL.CELLMARK   54225-8   Flow cytometry     Order       0 Immune response Pnl Spec FC       N   CELL MARKERS; Dynamic; FC; Imm; Immune response Pnl; Imun; Imune; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.69 2.27   Panel                   0
54226-6 Lymphoma panel - XXX Pt - Flow cytometry   ACTIVE Lymphoma panel - Specimen by Flow cytometry (FC)   MIN DefinitionDescription                   PANEL.CELLMARK   54226-6   Flow cytometry     Order       0 Lymphoma Pnl Spec FC       N   CELL MARKERS; Dynamic; FC; Lymphoma Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified 2.73 2.27   Panel                   0
54227-4 Lymphoma - acute screen panel - XXX Pt - Flow cytometry   ACTIVE Lymphoma - acute screen panel - Specimen by Flow cytometry (FC)   MIN DefinitionDescription                   PANEL.CELLMARK   54227-4   Flow cytometry     Order       0 Lymphoma - acute screen Pnl Spec FC       N   CELL MARKERS; Dynamic; FC; Lymphoma - acute screen Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified 2.69 2.27   Panel                   0
54228-2 Lymphoma - CLL screen panel - XXX Pt - Flow cytometry   ACTIVE Lymphoma - CLL screen panel - Specimen by Flow cytometry (FC)   MIN DefinitionDescription                   PANEL.CELLMARK   54228-2   Flow cytometry     Order       0 Lymphoma - CLL screen Pnl Spec FC       N   CELL MARKERS; Chronic lymphocytic leukemia; Dynamic; FC; Lymphoma - CLL screen Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified 2.73 2.27   Panel                   0
54229-0 Lymphoma - T-cell screen panel - XXX Pt - Flow cytometry   ACTIVE Lymphoma - T-cell screen panel - Specimen by Flow cytometry (FC)   MIN DefinitionDescription                   PANEL.CELLMARK   54229-0   Flow cytometry     Order       0 Lymphoma - T-cell screen Pnl Spec FC       N   CELL MARKERS; Dynamic; FC; Lymphoma - T-cell screen Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Spec; T cell; T prime; To be specified in another part of the message; UCHL-1; UniversalLabOrders; Unspecified 2.69 2.27   Panel                   0
104,672 results found